IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease.
Scott IC, Zuydam NV, Cann JA, Negri VA, Tsafou K, Killick H, Liu Z, McCrae C, Rees DG, England E, Guscott MA, Houslay K, McCormick D, Freeman A, Schofield D, Freeman A, Cohen ES, Thwaites R, Brohawn Z, Platt A, Openshaw PJM, Semple MG, Baillie JK, Wilkinson T; ISARIC4C Investigators.
Scott IC, et al. Among authors: platt a.
Mucosal Immunol. 2024 Dec 9:S1933-0219(24)00124-7. doi: 10.1016/j.mucimm.2024.12.001. Online ahead of print.
Mucosal Immunol. 2024.
PMID: 39662674
Free article.